Nicholas C Prairie

Title: Innovations of Nicholas C Prairie in Insulin-like Growth Factor-1 Analogues

Introduction

Nicholas C Prairie is an accomplished inventor based in Franklin, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel analogues of insulin-like growth factor-1 (IGF-1). His work focuses on addressing various medical conditions through innovative pharmaceutical compositions.

Latest Patents

Nicholas C Prairie holds a patent for "Analogues of insulin-like growth factor-1 (IGF-1) having amino acid substitution at position 59." This invention relates to novel analogues of IGF-1, which are designed for the treatment of IGF-1-receptor mediated conditions. These conditions include short stature, diabetes therapy, neurodegenerative disease treatment, and cartilage repair. The patent specifically highlights analogues such as (Asn)hIGF-1(1-70)-OH (SEQ ID NO:1) and other defined substitutions.

Career Highlights

Nicholas is associated with Ipsen Pharma S.a.s., where he continues to advance his research and development efforts. His work has the potential to impact the treatment landscape for various health conditions, showcasing his commitment to innovation in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Zheng Xin Dong and Maria L Ufret, who contribute to the collaborative efforts in research and development at Ipsen Pharma S.a.s.

Conclusion

Nicholas C Prairie's innovative work in the field of insulin-like growth factor-1 analogues exemplifies the importance of research in developing effective treatments for critical health issues. His contributions are paving the way for advancements in medical therapies.